Custom cancer vaccine tested in early safety trial
Disease control
Completed
This early-stage study tested whether a personalized vaccine, made from a patient's own tumor, could be safely created and given to people with advanced cancers that no longer respond to standard treatments. The vaccine was combined with an immunotherapy drug (pembrolizumab) to t…
Phase: PHASE1 • Sponsor: Aaron Miller • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC